CBI Natural Policosanol 40mg with CoQ10 Tablet
CBI Natural Policosanol 40mg with CoQ10 Tablet, NPN 80093881: natural health product licensed in Canada. Medicinal ingredients: 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl, Policosanol.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 30 mg | Not calculated |
| Policosanol Source : Policosanol | 40 mg | Not calculated |
| Policosanol Source : Saccharum officinarum - cire | 40 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Dioxyde de titane, Acide stéarique, Hypromellose, Stéarate de magnésium, Dioxyde de silicium colloïdal, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Helps to support cardiovascular health. An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. IIf you are taking medications, particularly hydroxymethylglutaryl (HMG) CoA reductase lipid-lowering drugs (such as statins), cyclosporine, anti-diabetic drugs, anti-platelet drugs (such as acetylsalicyclic or ASA), anti-coagulants (such as warfarin), blood pressure medication, and/or blood thinners, consult a health care practitioner prior to use.
Product record
- Other names
- Herb Canada Policosanol 40mg with CoQ10 Tablet
- Licence holder
- CBI INTERNATIONAL
- NPN or DIN-HM
- 80093881
- Status
- Active licence
- Licence date
- 12 August 2019
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80093881
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “CBI Natural Policosanol 40mg with CoQ10 Tablet (CBI INTERNATIONAL): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80093881-cbi-natural-policosanol-40mg-with-coq10-tablet, updated 12 August 2019.